29 May, 2026
29 May, 2026
HPV infection in men is one of the most underaddressed topics in men's health today. Human papillomavirus (HPV) is one of the most common sexually transmitted infections affecting both men and women globally. Human papillomavirus spreads through skin-to-skin contact during sexual activity and, in most cases, produces no symptoms at all.
When high-risk strains are involved, HPV connects directly to oropharyngeal cancer, anal cancer, and penile cancer. Understanding transmission, recognizing HPV infection symptoms in males, and knowing what prevention options exist can change outcomes significantly.
HPV is not a fringe concern. In India, ICMR has flagged rising HPV-linked cancers in men, particularly oropharyngeal and anal cancers, as a growing clinical priority.
When HPV infection symptoms in males appear, they vary by strain and location. Grouping them helps identify what to watch for:
Soft, painless warts near the penis, scrotum, or groin, appearing weeks or months after exposure.
A sore throat that will not resolve, voice changes, persistent mouth sores, or difficulty swallowing.
Itching, bleeding, discomfort, or unusual tissue changes around the anal region.
A neck lump, non-healing skin on the penis, or unexplained ear pain. High-risk HPV strains linked to cancer typically show none of these signs and alter cells quietly over the years.
Genital HPV affects approximately 45% of men aged 18 to 59, per CDC survey data. Most infections clear on their own through natural immune response. The ones that persist, particularly high-risk strains, are where long-term cancer risk develops.
HPV transmission in couples happens through skin-to-skin genital contact. Penetration is not required. The virus passes through vaginal, oral, and anal activity and through genital touching, even when no visible symptoms exist. Both partners benefit from open conversations about sexual health and vaccination.
Yes. Men can carry and transmit high-risk HPV strains such as HPV 16 and HPV 18, which are strongly associated with cervical cancer in women. Although men cannot develop cervical cancer themselves, persistent exposure to these strains may increase long-term cervical cancer risk in unvaccinated partners
Male HPV awareness and vaccination, therefore, play an important role in protecting both individual and partner health.
Persistent exposure to high-risk HPV strains may increase long-term cervical cancer risk in unvaccinated partners. Male HPV awareness and vaccination carry consequences well beyond individual health.
| HPV Type | Risk Category | Associated Conditions |
|---|---|---|
| HPV 6 & 11 | Low-risk | Genital warts |
| HPV 16 & 18 | High-risk | Oropharyngeal, anal, penile, and cervical cancers |
Low-risk types like HPV 6 and 11 cause genital warts, which are uncomfortable but not cancer-linked. High-risk HPV in men, primarily HPV 16 and 18, rarely produces visible symptoms. Instead, these strains damage cells slowly over time, and by the time anything becomes noticeable, the process may have already progressed significantly.
Yes. Persistent high-risk HPV infection in men can increase the risk of throat, anal, and penile cancers. For most men, the infection resolves without lasting harm. For those carrying a persistent high-risk strain, the risk is real.
When high-risk strains persist, yes, oropharyngeal, anal, and penile cancers all link directly to long-term HPV infection. Without routine male screening programs, these cancers are frequently caught late.
Modern oncology research strongly links persistent high-risk HPV infection to multiple cancers affecting men. HPV-related cancers in men have been rising steadily for over two decades. Oropharyngeal cancer, affecting the throat, tonsils, and base of the tongue, currently leads the list. Anal cancer and penile cancer follow, both strongly connected to long-term high-risk HPV infection.
The following cancers carry a well-established connection to HPV infection in men:
| Cancer Type | Affected Area | Common Early Signs |
|---|---|---|
| Oropharyngeal cancer | Throat, tonsils, tongue base | Lingering sore throat, voice changes |
| Anal cancer | Anal canal | Bleeding, pain, lumps |
| Penile cancer | Penile skin and tissue | Non-healing sores, skin changes |
| Head and neck cancers | Mouth, larynx, pharynx | Mouth sores, swallowing difficulty |
Most men find out when a wart appears or when a partner receives an HPV-related diagnosis. There is no national routine screening program for HPV in men. Diagnosis typically happens through physical examination, tissue biopsy, or targeted swabs for higher-risk individuals.
Moving from cancer risk to detection: male HPV testing has no reliable, standardized blood test equivalent to the Pap smear for women. That gap is real, but it does not mean nothing can be done. A doctor can assess symptoms and individual risk history and recommend appropriate investigation.
In certain high-risk individuals, doctors may recommend anal Pap testing, biopsy evaluation, or specialist examination depending on symptoms and medical history. Men with concerns should consult a specialist directly.
Yes. Most HPV infections in men clear naturally within one to two years through the body's immune response. High-risk strains resist clearance more often. When they persist, cellular damage compounds quietly over time. No antiviral drug eliminates HPV once present. Management focuses on treating what the virus causes, while prevention focuses on blocking strains not yet encountered.
This remains an emerging research area. Some studies suggest HPV may affect sperm motility and DNA integrity, but current evidence is not conclusive. Men with a confirmed persistent infection who are trying to conceive should discuss this individually with a fertility specialist.
The HPV vaccine, Gardasil 9, targets nine strains, covering high-risk cancer-linked types and low-risk wart-causing types. Two doses are given between the ages of 9 -14, and three doses for anyone starting at age 15. The vaccine works before exposure and cannot treat an infection already present.
Yes. HPV vaccination helps reduce the risk of genital warts, HPV-related cancers, and virus transmission to partners. Standard catch-up vaccination is recommended up to age 26. Between 27 and 45, it remains worth discussing with a doctor based on individual risk.
HPV prevention works best as a layered behavioral approach:
Preventive healthcare measures such as HPV vaccination, routine medical consultations, and early symptom evaluation can significantly reduce long-term cancer risk.
Among sexually transmitted infections, HPV stands apart for how silently it moves through male populations. No obvious symptoms, no standard screening, yet direct consequences for both the carrier and his partners. Incorporating HPV into routine men's health checkups is one of the most practical prevention steps available.
HPV awareness turns risk into action. Increasing cancer awareness among men is important because HPV-related cancers are often diagnosed at later stages. When men understand how the virus spreads, what it can lead to, and what tools exist to stop it, prevention becomes something concrete. HPV-related cancers in men are largely preventable. Vaccination exists.
Specialist evaluation is accessible. Acting before symptoms appear is where awareness makes the greatest difference. Because HPV often spreads silently, many men unknowingly transmit the virus long before symptoms appear.
HPV infection in men is common, usually silent, and tied to cancers that do not have to happen. Vaccination, early consultation, and preventive screening each play a direct role.
At HCG Cancer Hospital, specialist oncology teams across 25 comprehensive cancer centers in India offer dedicated support for HPV-related cancer prevention, early detection, and treatment. With over 35 years of oncology experience, HCG provides the clinical expertise needed at every stage of care.
Book a consultation with an oncology specialist today to discuss HPV vaccination, symptom evaluation, and cancer prevention strategies.
Disclaimer: This article is for general informational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Please consult a qualified healthcare provider for any questions regarding a medical condition.
Feel free to reach out to us.
